Shyam Kambeyanda
Analyst · Loop Capital
Thank you, Mark, and good morning, everyone. Thank you for joining us today. Let me start by reminiscing a bit. April 5 was a fantastic day for ESAB being listed on the New York Stock Exchange was a source of profound pride for all of our global associates. Over the last 5 years, we've made solid progress and have confidence in our strategic direction moving forward. As a team, we're focused on taking our ESAB business system that we call EBX up a notch to continue to drive innovation, growth, margin expansion, better cash flow and breakthrough strategies to deliver long term shareholder value.
Turning to Slide 3. I am pleased to report another quarter of strong results. We extended our outperformance on volume growth and improved our margins year over year. I am very proud of our team's focus and determination as we successfully navigated headwinds due to COVID restrictions in China and the war in Ukraine. In terms of financials, in the first quarter, we delivered a record of $648 million in sales, 18% year over year, organic growth, which reflected strong price realization and a broad based demand for innovative solutions. EBITDA climb to $109 million, a 16% increase year over year. Our margins expanded 30 basis points to 16.9%. We continue to introduce exciting new products and as I mentioned before, we have taken our EBX efforts up a notch, and I will share more on both these topics in the next 2 slides.
Now moving the Slide 4. We launched 28 new products in Q1 and continue to prioritize investment in R&D. Our open innovation process has allowed ESAB to accelerate the pace of innovation. For the full year we are on target to launch approximately 110 new products. And we take a bit of time to highlight some of them. RobustFeed, this is an award-winning feeder that is used in heavy industrial applications. during the quarter, we redesigned the unit so that it can connect to any power source, helping us expand the market for this product.
The fabricator has new and upgraded technology that simplifies our product line and provides a competitive offering to our customers. I have mentioned product line rationalization in the past. This accelerates our rough efforts to rationalize our SKUs and improve margins going forward. Our gas control bus business also launch some exciting new products in the first quarter, the druvaPUR, High Purity and MediVital, these are great examples of us designing the best in class technology and expanding into new geographies.
Moving to Slide 5. I'm really excited about the next phase of EBX. And I wanted to share with you some examples of Kaizen as we completed in the first quarter, we continue our EBX journey to improve safety and productivity while reducing our footprint. In the first quarter, we completed 10 major Kaizen in North America, which resulted in $3 million in productivity savings. These Kaizens also freed up over 5,000 square feet of manufacturing and assembly space.
The main tenant of our Kaizen is to improve quality, productivity and safety with minimal capital investments. And that's exactly what we did in the example I'm sharing with you. At our Denton facility, one of our key product lines, we increased sales per month by over 40% and improved productivity by 42% gain manufacturing space and improved safety. I will be visiting the Denton facility later this month to celebrate with our team.
Moving to Slide 6. First quarter 2022 sales rose to a record $648 million, a 14% increase year-over-year, 18% organically. This reflected a volume increase of 4%, a price increase of 14 and a 400 basis points of currency impact. We continue to experience healthy demand across most geographies. A real highlight to this quarter was record equipment sales at ESA. The regions where we experienced lower sales were Russia as expected and China due to COVID lockdowns.
Our teams continue to do a fantastic job managing price to offset the impact of inflation. With our focus on margin expansion, EBITDA increased to $109 million up 16% and expanded margins, 30 basis points to 16.9% with a strong year over year performance from our America's unit.
Moving to Slide 7 and talking specifically about our America segments. The America segments performed well as sales climbed to $272 million, a 21% growth organically. This reflected increases in volume of 3% and a price of 18% with a slight currency headwind. We are continuing to make good progress, our new and improved product offering our driving growth in the channel. EBITDA increased by 32% margins expanded by 150 basis points, reflecting strong execution as our team successfully managed through inflation and supply chain constraints.
Earlier, I shared our lean activities and I am very proud of our team and what we are building together. We have lots of exciting new products under development, which will drive future growth and margin expansion. And I'll share more in due time.
On to Slide 8. Now talking about our EMEA and APAC segments. Our EMEA and APAC segments perform well despite headwinds in the quarter from COVID in China and the war in Ukraine. First quarter sales increased 10% and climbed 16% organically. This reflected a volume increase of 4% of price of 12 and a 600 basis points of currency headwind. This region also saw record equipment sales. Another highlight in the quarter was the momentum we are building in robotics and well cloud solutions, driving growth in both our funnel and auto backlog. EBITDA increased 7% in the quarter. EBITDA was 17.4%. This included approximately 4 million provision related to Russia without which margins would have increased 50 basis points year over year. I'm very proud of our teams in Europe, Middle East and Asia during these challenging times, they have performed extraordinarily well and have built great momentum.
Moving to Slide 9. Let me turn it over to Kevin.